Cargando…
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Recently, peroxisome proliferator-activated receptor (PPAR)-α and γ isoforms have been gaining consistent interest in neuropathology and treatment of neuropsychiatric disorders. Several studies have provided evidence that either the receptor expression or the levels of their endogenously-produced mo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179196/ https://www.ncbi.nlm.nih.gov/pubmed/32120979 http://dx.doi.org/10.3390/molecules25051062 |